Sorrentino Lorena, Serra Francesco, Cabry Francesca, De Julis Stefano, Barbieri Elisa, Girardis Massimo, Ceccarelli Pier Luca, Gelmini Roberta
Department of Surgery, University of Modena and Reggio Emilia - Policlinico of Modena, Via del Pozzo, 71, 41100 Modena, Italy.
Department of Anesthesiology, University of Modena and Reggio Emilia - Policlinico of Modena, Via del Pozzo, 71, 41100 Modena, Italy.
Int J Surg Case Rep. 2019;57:118-121. doi: 10.1016/j.ijscr.2019.02.046. Epub 2019 Mar 21.
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is nowadays a feasible and effective treatment for peritoneal metastasis. We present a case of a 14 years old child with peritoneal metastasis from recurrent colorectal cancer.
Colonoscopy and CT-scan were performed leading to the diagnosis of a stenosing adenocarcinoma of the right colon in 2015. Two pelvic lesions were found at the total body PET scan, suspected for peritoneal metastasis. Neoadjuvant chemotherapy was administered, and restaging CT-scan and magnetic resonance (MRI) highlighted a partial response. The patient underwent right laparoscopic hemicolectomy. The postoperative staging was T4 N1 G3. Seven months after the last cycle of adjuvant chemotherapy, CT-scan revealed two huge abdominal masses. The patient underwent explorative laparotomy and bilateral oophorectomy, positive for metastasis from colorectal cancer and peritoneal washing cytology was positive for neoplastic cells. A CT-scan was performed on December 2017 showed a suspect lesion below the anterior abdominal wall. The case was discussed at the tumour board and the indication for CRS and HIPEC was given. In January 2018 the child underwent complete CRS and HIPEC with no complications. No adjuvant chemotherapy was administered. After 11 months the follow up is negative for the recurrent disease.
Cytoreduction and HIPEC can be performed even in children as a feasible and safe treatment with successful outcomes. As for adults, an appropriate multidisciplinary pre-operative work up and a correct cases selection is needed to have the best results even regarding the quality of life.
细胞减灭术(CRS)和腹腔热灌注化疗(HIPEC)如今是治疗腹膜转移的一种可行且有效的方法。我们报告一例14岁儿童复发性结直肠癌伴腹膜转移的病例。
2015年进行了结肠镜检查和CT扫描,诊断为右半结肠癌伴狭窄性腺癌。全身PET扫描发现两个盆腔病变,怀疑为腹膜转移。给予新辅助化疗,重新分期的CT扫描和磁共振成像(MRI)显示部分缓解。患者接受了腹腔镜右半结肠切除术。术后分期为T4 N1 G3。在最后一个周期辅助化疗7个月后,CT扫描显示两个巨大的腹部肿块。患者接受了剖腹探查术和双侧卵巢切除术,结果显示为结直肠癌转移阳性,腹腔冲洗细胞学检查发现肿瘤细胞阳性。2017年12月的CT扫描显示前腹壁下方有一个可疑病变。该病例在肿瘤多学科讨论会上进行了讨论,并给出了CRS和HIPEC的治疗指征。2018年1月,该患儿接受了完整的CRS和HIPEC,无并发症发生。未给予辅助化疗。11个月后随访显示无复发病例。
即使是儿童患者,细胞减灭术和HIPEC也可作为一种可行且安全的治疗方法,且疗效良好。与成人一样,需要进行适当的多学科术前评估和正确的病例选择,以获得最佳结果,包括生活质量方面。